{"DataElement":{"publicId":"5228984","version":"1","preferredName":"Second Part Tumor Tissue Sent To Tissue Bank Malignant Neoplasm Percentage Value","preferredDefinition":"The tumor content of the second piece of material sent to the tissue bank expressed as a percentage.","longName":"SCND_TUM_MLG_PCT_VAL","context":"BBRB","contextVersion":"1","DataElementConcept":{"publicId":"5227257","version":"1","preferredName":"Second Part Tumor Tissue Sent To Tissue Bank Malignant Neoplasm Content","preferredDefinition":"Coming next after the first in position in space or time or degree or magnitude._One of the portions into which something is regarded as divided and which together constitute a whole._A tumor sample, or entire tumor that is removed for microscopic examination._Cause or enable to go or be conveyed or transmitted._Used as a function word to indicate direction, purpose, or movement._A repository of the tissue specimen, cells or cell lines, for experimental purpose. It can be from different diseases or different parts of the body._A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas._Everything that is included in a collection, container, or communication.","longName":"5408252v1.0:5408253v1.0","context":"BBRB","contextVersion":"1","ObjectClass":{"publicId":"5408252","version":"1","preferredName":"Second Part Tumor Tissue","preferredDefinition":"Coming next after the first in position in space or time or degree or magnitude.:One of the portions into which something is regarded as divided and which together constitute a whole.:A tumor sample, or entire tumor that is removed for microscopic examination.","longName":"C25666:C45313:C18009","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Second","conceptCode":"C25666","definition":"Coming next after the first in position in space or time or degree or magnitude.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Part","conceptCode":"C45313","definition":"One of the portions into which something is regarded as divided and which together constitute a whole.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Tumor Tissue Sample","conceptCode":"C18009","definition":"Tissue sample that contains an abnormal cellular infiltrate forming a solid mass. The abnormal cellular component can be benign or malignant. Tumor samples are obtained for microscopic examination and/or molecular analysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3A23F272-940B-A44F-E050-BB89AD430523","latestVersionIndicator":"Yes","beginDate":"2016-08-15","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-08-15","modifiedBy":"ONEDATA","dateModified":"2016-08-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"5408253","version":"1","preferredName":"Send To Tissue Collection Malignant Neoplasm Content","preferredDefinition":"Cause or enable to go or be conveyed or transmitted.:Used as a function word to indicate direction, purpose, or movement.:A repository of the tissue specimen, cells or cell lines, for experimental purpose. It can be from different diseases or different parts of the body.:A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.:Everything that is included in a collection, container, or communication.","longName":"5408253v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Send","conceptCode":"C25672","definition":"Cause or enable to go or be conveyed or transmitted.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"To","conceptCode":"C65107","definition":"Used as a function word to indicate direction, purpose, or movement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Tissue Collection","conceptCode":"C15339","definition":"A repository of the tissue specimen, cells or cell lines, for experimental purpose. It can be from different diseases or different parts of the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Content","conceptCode":"C44476","definition":"Everything that is included in a collection, container, or communication.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3A23F272-941F-A44F-E050-BB89AD430523","latestVersionIndicator":"Yes","beginDate":"2016-08-15","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-08-15","modifiedBy":"ONEDATA","dateModified":"2016-08-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"BPV: Biospecimen Pre-analytical Variables (BPV) Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"30CD23D5-77DD-F91B-E050-BB89AD431792","latestVersionIndicator":"Yes","beginDate":"2016-04-18","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-18","modifiedBy":"HARTLEYG","dateModified":"2016-08-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3382692","version":"1","preferredName":"Percentage Value","preferredDefinition":"the numerical quantity measured or assigned or computed as a fraction or ratio with 100 understood as the denominator.","longName":"PCT_VAL","context":"NCIP","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":"8","minValue":null,"maxValue":null,"decimalPlace":"3","format":"%","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008541","version":"1","preferredName":"Numbers","preferredDefinition":"the set of non-negative integers.","longName":"NUMS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B227CE66-2830-4A7B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2208119","version":"1","preferredName":"Percentage Value","preferredDefinition":"Percentage; a fraction or ratio with 100 understood as the denominator.:A numerical quantity measured or assigned or computed.","longName":"C25613:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3E46-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B99068EB-6BAA-AE1D-E040-BB89AD4362C9","latestVersionIndicator":"Yes","beginDate":"2012-02-22","endDate":null,"createdBy":"MAESKEB","dateCreated":"2012-02-22","modifiedBy":"KNABLEJ","dateModified":"2022-03-23","changeDescription":"3/23/22 jk added \"Qualified\" RS as part of MCL quarterly content review.  --- Display of XXXXX.XXX for Theradex application.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5188870","version":"1","longName":"BPV - Tumor Biospecimen Acquisition","context":"BBRB","ClassificationSchemeItems":[{"publicId":"5405791","version":"1","longName":"BPV - Tumor Biospecimen Acquisition","context":"BBRB"},{"publicId":"6736427","version":"1","longName":"Tissue Gross Evaluation","context":"BBRB"}]}],"AlternateNames":[{"name":"BBRB","type":"USED_BY","context":"BBRB"}],"ReferenceDocuments":[{"name":"Percentage of tumor content o","type":"Preferred Question Text","description":"Percentage of tumor content of second piece of tumor tissue sent to tissue bank (if applicable)","url":null,"context":"BBRB"}],"origin":"BPV: Biospecimen Pre-analytical Variables (BPV) Program","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"30EFF8EE-1B34-4F6C-E050-BB89AD432AE5","latestVersionIndicator":"Yes","beginDate":"2016-04-20","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-20","modifiedBy":"HARTLEYG","dateModified":"2019-04-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}